nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2C19—Teniposide—lymphatic system cancer	0.125	0.393	CbGbCtD
Pentobarbital—CYP3A4—Cytarabine—lymphatic system cancer	0.0612	0.193	CbGbCtD
Pentobarbital—CYP3A4—Teniposide—lymphatic system cancer	0.0603	0.19	CbGbCtD
Pentobarbital—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0422	0.133	CbGbCtD
Pentobarbital—Hypoxia—Fludarabine—lymphatic system cancer	0.0395	0.0578	CcSEcCtD
Pentobarbital—Anaemia megaloblastic—Methotrexate—lymphatic system cancer	0.0315	0.0462	CcSEcCtD
Pentobarbital—CYP3A4—Vincristine—lymphatic system cancer	0.029	0.0914	CbGbCtD
Pentobarbital—Respiratory failure—Fludarabine—lymphatic system cancer	0.0255	0.0374	CcSEcCtD
Pentobarbital—Injection site reaction—Carmustine—lymphatic system cancer	0.0159	0.0234	CcSEcCtD
Pentobarbital—Respiratory failure—Vincristine—lymphatic system cancer	0.0156	0.0229	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0155	0.0227	CcSEcCtD
Pentobarbital—Hypoxia—Methotrexate—lymphatic system cancer	0.0117	0.0171	CcSEcCtD
Pentobarbital—Agitation—Teniposide—lymphatic system cancer	0.0115	0.0168	CcSEcCtD
Pentobarbital—Ataxia—Carmustine—lymphatic system cancer	0.0109	0.016	CcSEcCtD
Pentobarbital—Ataxia—Vincristine—lymphatic system cancer	0.0105	0.0153	CcSEcCtD
Pentobarbital—Confusional state—Teniposide—lymphatic system cancer	0.0103	0.015	CcSEcCtD
Pentobarbital—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0102	0.0149	CcSEcCtD
Pentobarbital—Agitation—Fludarabine—lymphatic system cancer	0.0101	0.0148	CcSEcCtD
Pentobarbital—Hypotension—Teniposide—lymphatic system cancer	0.00951	0.0139	CcSEcCtD
Pentobarbital—Confusional state—Fludarabine—lymphatic system cancer	0.00902	0.0132	CcSEcCtD
Pentobarbital—Vomiting—Mechlorethamine—lymphatic system cancer	0.00878	0.0129	CcSEcCtD
Pentobarbital—Apnoea—Methotrexate—lymphatic system cancer	0.00877	0.0128	CcSEcCtD
Pentobarbital—Rash—Mechlorethamine—lymphatic system cancer	0.0087	0.0128	CcSEcCtD
Pentobarbital—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00869	0.0127	CcSEcCtD
Pentobarbital—Feeling abnormal—Teniposide—lymphatic system cancer	0.00839	0.0123	CcSEcCtD
Pentobarbital—Nausea—Mechlorethamine—lymphatic system cancer	0.0082	0.012	CcSEcCtD
Pentobarbital—Body temperature increased—Teniposide—lymphatic system cancer	0.00804	0.0118	CcSEcCtD
Pentobarbital—Hallucination—Carmustine—lymphatic system cancer	0.00802	0.0117	CcSEcCtD
Pentobarbital—Hallucination—Vincristine—lymphatic system cancer	0.00765	0.0112	CcSEcCtD
Pentobarbital—Constipation—Fludarabine—lymphatic system cancer	0.00765	0.0112	CcSEcCtD
Pentobarbital—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00762	0.0112	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—lymphatic system cancer	0.00757	0.0111	CcSEcCtD
Pentobarbital—Hypersensitivity—Teniposide—lymphatic system cancer	0.0075	0.011	CcSEcCtD
Pentobarbital—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00737	0.0108	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00718	0.0105	CcSEcCtD
Pentobarbital—Body temperature increased—Fludarabine—lymphatic system cancer	0.00707	0.0104	CcSEcCtD
Pentobarbital—Confusional state—Bleomycin—lymphatic system cancer	0.00661	0.00969	CcSEcCtD
Pentobarbital—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00659	0.00965	CcSEcCtD
Pentobarbital—Vomiting—Teniposide—lymphatic system cancer	0.00647	0.00948	CcSEcCtD
Pentobarbital—Agitation—Carmustine—lymphatic system cancer	0.00644	0.00944	CcSEcCtD
Pentobarbital—Rash—Teniposide—lymphatic system cancer	0.00642	0.0094	CcSEcCtD
Pentobarbital—Dermatitis—Teniposide—lymphatic system cancer	0.00641	0.00939	CcSEcCtD
Pentobarbital—Headache—Teniposide—lymphatic system cancer	0.00637	0.00934	CcSEcCtD
Pentobarbital—Agitation—Vincristine—lymphatic system cancer	0.00615	0.00901	CcSEcCtD
Pentobarbital—Hypotension—Bleomycin—lymphatic system cancer	0.00613	0.00898	CcSEcCtD
Pentobarbital—Nausea—Teniposide—lymphatic system cancer	0.00604	0.00886	CcSEcCtD
Pentobarbital—Anxiety—Carmustine—lymphatic system cancer	0.00595	0.00872	CcSEcCtD
Pentobarbital—Confusional state—Carmustine—lymphatic system cancer	0.00577	0.00846	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00572	0.00838	CcSEcCtD
Pentobarbital—Vomiting—Fludarabine—lymphatic system cancer	0.00569	0.00833	CcSEcCtD
Pentobarbital—Rash—Fludarabine—lymphatic system cancer	0.00564	0.00826	CcSEcCtD
Pentobarbital—Dermatitis—Fludarabine—lymphatic system cancer	0.00563	0.00825	CcSEcCtD
Pentobarbital—Headache—Fludarabine—lymphatic system cancer	0.0056	0.00821	CcSEcCtD
Pentobarbital—Anxiety—Mitoxantrone—lymphatic system cancer	0.00553	0.00811	CcSEcCtD
Pentobarbital—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0054	0.00792	CcSEcCtD
Pentobarbital—Confusional state—Mitoxantrone—lymphatic system cancer	0.00537	0.00786	CcSEcCtD
Pentobarbital—Hypotension—Carmustine—lymphatic system cancer	0.00535	0.00784	CcSEcCtD
Pentobarbital—Nausea—Fludarabine—lymphatic system cancer	0.00531	0.00778	CcSEcCtD
Pentobarbital—Shock—Mitoxantrone—lymphatic system cancer	0.00523	0.00767	CcSEcCtD
Pentobarbital—Body temperature increased—Bleomycin—lymphatic system cancer	0.00518	0.0076	CcSEcCtD
Pentobarbital—Hypotension—Vincristine—lymphatic system cancer	0.00511	0.00748	CcSEcCtD
Pentobarbital—Somnolence—Carmustine—lymphatic system cancer	0.00509	0.00746	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—lymphatic system cancer	0.00507	0.00743	CcSEcCtD
Pentobarbital—Hypotension—Mitoxantrone—lymphatic system cancer	0.00497	0.00729	CcSEcCtD
Pentobarbital—Constipation—Carmustine—lymphatic system cancer	0.00489	0.00717	CcSEcCtD
Pentobarbital—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00483	0.00708	CcSEcCtD
Pentobarbital—Somnolence—Mitoxantrone—lymphatic system cancer	0.00473	0.00693	CcSEcCtD
Pentobarbital—Feeling abnormal—Carmustine—lymphatic system cancer	0.00472	0.00691	CcSEcCtD
Pentobarbital—Constipation—Vincristine—lymphatic system cancer	0.00467	0.00685	CcSEcCtD
Pentobarbital—Constipation—Mitoxantrone—lymphatic system cancer	0.00455	0.00667	CcSEcCtD
Pentobarbital—Body temperature increased—Carmustine—lymphatic system cancer	0.00452	0.00663	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00438	0.00643	CcSEcCtD
Pentobarbital—Body temperature increased—Vincristine—lymphatic system cancer	0.00432	0.00633	CcSEcCtD
Pentobarbital—Hypersensitivity—Carmustine—lymphatic system cancer	0.00422	0.00618	CcSEcCtD
Pentobarbital—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00421	0.00616	CcSEcCtD
Pentobarbital—Vomiting—Bleomycin—lymphatic system cancer	0.00417	0.00611	CcSEcCtD
Pentobarbital—Rash—Bleomycin—lymphatic system cancer	0.00413	0.00606	CcSEcCtD
Pentobarbital—Dermatitis—Bleomycin—lymphatic system cancer	0.00413	0.00605	CcSEcCtD
Pentobarbital—Hypersensitivity—Vincristine—lymphatic system cancer	0.00403	0.0059	CcSEcCtD
Pentobarbital—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00392	0.00574	CcSEcCtD
Pentobarbital—Nausea—Bleomycin—lymphatic system cancer	0.00389	0.00571	CcSEcCtD
Pentobarbital—Dizziness—Carmustine—lymphatic system cancer	0.00378	0.00555	CcSEcCtD
Pentobarbital—Vomiting—Carmustine—lymphatic system cancer	0.00364	0.00533	CcSEcCtD
Pentobarbital—Dizziness—Vincristine—lymphatic system cancer	0.00361	0.00529	CcSEcCtD
Pentobarbital—Rash—Carmustine—lymphatic system cancer	0.00361	0.00529	CcSEcCtD
Pentobarbital—Dermatitis—Carmustine—lymphatic system cancer	0.00361	0.00528	CcSEcCtD
Pentobarbital—Headache—Carmustine—lymphatic system cancer	0.00359	0.00525	CcSEcCtD
Pentobarbital—Vomiting—Vincristine—lymphatic system cancer	0.00347	0.00509	CcSEcCtD
Pentobarbital—Rash—Vincristine—lymphatic system cancer	0.00344	0.00505	CcSEcCtD
Pentobarbital—Dermatitis—Vincristine—lymphatic system cancer	0.00344	0.00504	CcSEcCtD
Pentobarbital—Headache—Vincristine—lymphatic system cancer	0.00342	0.00502	CcSEcCtD
Pentobarbital—Nausea—Carmustine—lymphatic system cancer	0.0034	0.00498	CcSEcCtD
Pentobarbital—Vomiting—Mitoxantrone—lymphatic system cancer	0.00338	0.00496	CcSEcCtD
Pentobarbital—Rash—Mitoxantrone—lymphatic system cancer	0.00335	0.00492	CcSEcCtD
Pentobarbital—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00335	0.00491	CcSEcCtD
Pentobarbital—Headache—Mitoxantrone—lymphatic system cancer	0.00333	0.00488	CcSEcCtD
Pentobarbital—Nausea—Vincristine—lymphatic system cancer	0.00325	0.00476	CcSEcCtD
Pentobarbital—Nausea—Mitoxantrone—lymphatic system cancer	0.00316	0.00463	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—lymphatic system cancer	0.00267	0.00392	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—lymphatic system cancer	0.00248	0.00363	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—lymphatic system cancer	0.00236	0.00345	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00218	0.0032	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—lymphatic system cancer	0.0021	0.00307	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00195	0.00286	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—lymphatic system cancer	0.00175	0.00257	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—lymphatic system cancer	0.00169	0.00247	CcSEcCtD
Pentobarbital—Rash—Methotrexate—lymphatic system cancer	0.00167	0.00245	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—lymphatic system cancer	0.00167	0.00245	CcSEcCtD
Pentobarbital—Headache—Methotrexate—lymphatic system cancer	0.00166	0.00243	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—lymphatic system cancer	0.00157	0.00231	CcSEcCtD
